ABSTRACT
Background
Long-term follow-up studies on primary aldosteronism (PA) are lacking.
Objective
We aim to review results of diagnostic procedures and histopathology for patients diagnosed during 2012–2016 in Iceland, compare unilateral (UD) and bilateral disease (BD) and assess treatment response.
Methods
Thirty-two patients aged 28–88 were diagnosed and treated according to guidelines.
Results
The majority had BD. Everyone needed potassium supplementation at case detection. We saw a reduction in systolic blood pressure (p < .001, both groups), antihypertensive agents (p = .002 UD and p = .04 BD) and potassium supplementation (p < .001, both groups).
Conclusion
Similar treatment response was seen in both subgroups. Ratio of hypokalemia and number of cases indicates severe PA underdiagnosis in Iceland.
Acknowledgments
The authors want to thank Ubaldo Benitez Hernandez, statistician and natural scientist at LUH, for his help with statistical analysis regarding follow-up, and Gudmundur Sigthorsson, MD, PhD, at LUH for assessing laboratory values.
Disclosure Statement
No potential conflict of interest was reported by the authors.
Data Availability Statement
Restrictions apply to the data supporting these findings because they were used under license. The corresponding author will on request detail the restrictions and any conditions under which access to some data may be provided.
Supplementary Material
Supplemental data for this article can be accessed on the publisher’s website.